Market Place
Sourcing Support
Acticor halts phase 2/3 stroke trial for blood thinner over futility
26 Jul 2024 //
FIERCE BIOTECH
ACTICOR Adapts Its ACTISAVE Study to Prepare the Registration of Glenzocimab
14 Sep 2023 //
BUSINESSWIRE
Acticor Biotech: Progress in Discussions with EU and US Regulatory Agencies
30 May 2023 //
BUSINESSWIRE
Update on Acticor Biotech`s clinical developments with glenzocimab
09 Jan 2023 //
BUSINESSWIRE
Acticor Biotech Receives EMA Endorsement on Key Parameters of ACTISAVE
05 Dec 2022 //
BUSINESSWIRE
Acticor and University of Birmingham partner for heart attack drug trial
23 Nov 2022 //
CLINICALTRIALSARENA
Acticor begins patient enrollment in phase 2/3 ACTISAVE study of glenzocimab
28 Sep 2022 //
PHARMABIZ
Acticor Biotech enrols first subject in Phase II/III stroke treatment trial
27 Sep 2022 //
CLINICALTRIALSARENA
Acticor Enrolled First US Patient in its Phase 2/3 Study ACTISAVE
26 Sep 2022 //
BUSINESSWIRE
Presentation of Positive Results From ACTIMIS PIa/IIb Study in Stroke at ESOC
09 May 2022 //
BUSINESSWIRE
Acticor Biotech Announces Its 2021 Full-year Financial Results
30 Mar 2022 //
BUSINESSWIRE
Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab
04 Nov 2021 //
BUSINESSWIRE
Acticor Announces the Completion of Enrollment in its GARDEN Clinical Trial
23 Jul 2021 //
BUSINESSWIRE
Acticor Biotech Announces the Completion of Enrollment in ACTIMIS
01 Jul 2021 //
BUSINESSWIRE
Acticor Appointments Mr Alain Munoz as Chairman of the Board of Director
15 Jun 2021 //
BUSINESSWIRE
Acticor Biotech Announces the Recruitment of the First Patient in its Phase 2
22 Dec 2020 //
BIOSPACE
Acticor Biotech Announces the Recruitment of the First Patient in its Ph2
22 Dec 2020 //
BUSINESSWIRE
Acticor Biotech Announces the Recruitment of th in its Pha2 GARDEN Study
22 Dec 2020 //
BIOSPACE
Acticor Biotech Announces the Recruitment of the First Patient in its Ph2 Study
22 Dec 2020 //
BUSINESSWIRE
Acticor Biotech Raises €7M In Addition to Its Series B Financing
06 Nov 2019 //
BUSINESSWIRE
Acticor Biotech Raises €7M In Addition to Its Series B Financing
06 Nov 2019 //
BUSINESSWIRE
Acticor`s blood thinner cuts hemorrhage risk in human study
18 Apr 2019 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.